Phase II Trial of Concurrent Administration of Intravesical BCG & Interferon in the Treatment and Prevention of Recurrence of Superficial Transitional Carcinoma of the Urinary Bladder

Femme et Homme

| Pays :
| Organes :
| Spécialités :

Extrait

Phase II Trial of concurrent administration of intravesical BCG & Interferon in the treatment and prevention of recurrence of superficial transitional carcinoma of the urinary bladder.

Critère d'inclusion

Transitional Carcinoma of Urinary Bladder

Liens

nct
ictrp